Picture of Burning Rock Biotech logo

BNR — Burning Rock Biotech News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Brief: Burning Rock Says Qtrly Loss Per Share For Class A And Class B Ordinary Shares $0.31

March 28 (Reuters) - Burning Rock Biotech Ltd  BNR.O :
    * BURNING ROCK REPORTS FOURTH QUARTER AND FULL YEAR 2022
FINANCIAL
RESULTS
    * WE CURRENTLY EXPECT OUR FULL YEAR 2023 REVENUES TO GROW
APPROXIMATELY 20% OVER 2022
    * BURNING ROCK BIOTECH - COMPANY PROMPTLY TRANSFERRED ITS
CASH
DEPOSITS AT SILICON VALLEY BANK TO ITS ACCOUNTS WITH OTHER MAJOR
FINANCIAL INSTITUTIONS
    * NO LOSS WAS INCURRED TO SUCH DEPOSITS
    * MAINTAIN BANK ACCOUNTS WITH A DIVERSIFIED SET OF FINANCIAL
INSTITUTIONS
    * QTRLY LOSS PER SHARE FOR CLASS A AND CLASS B ORDINARY
SHARES
$0.31

Source text for Eikon:  ID:nGNX5ppK1P 
Further company coverage:  BNR.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Burning Rock Biotech

See all news